Discovery Chemistry Congress
|Event Date/Time: Mar 19, 2013||End Date/Time: Mar 20, 2013|
Previous problems with drug discovery led to considerable investment by the pharmaceutical industry, in combinatorial and discovery chemistry. This conference will integrate the latest structural chemistry with innovative discovery-driven technologies. Taking place in Munich for the second year running, speakers will concentrate on the most important aspects of discovery stages for effective drug design and refinement.
In the current economic climate there is increasing global competitiveness and financial pressure, therefore, this conference aims to explore the options available to maximise the success of drug discovery and development.
Our speakers have collaborated to provide four accessible tracks:
- Fragment-based Lead Discovery
- Targeting Protein-protein Interactions
- Formulation & Solubility
- Chemical Biology
The tracks offered work synergistically to overcome the challenges of drug delivery in a completely new way. Select Biosciences hopes to help delegates convert this expensive, challenging and inefficient process into a more accessible and affordable one.
Roderic Hubbard, Professor, University of York
Barry Potter, Professor, University of Bath
Helena Danielson, Professor, Uppsala University
Mark Bradley, Professor/Principal Investigator, University of Edinburgh
Jennifer Laurence, Associate Professor, University of Kansas
Sven Stegemann, Director of Pharmaceutical Business Development, Pfizor
Andrei Gartel, Associate Professor, University of Illinois at Chicago
Arthur Olson, Professor, The Scripps Research Institute
Hiroaki Suga, Professor, The University of Tokyo
David Jones, Chair of Biomaterial Science and Director of Education, Queen's University of Belfast